The FDA Guidance on EDDO: What to Know, What to Do

Drug Delivery Leader Executive Editor Fran DeGrazio welcomed combination product regulatory experts in a candid conversation about the FDA’s recent draft guidance on Essential Drug Delivery Outputs (EDDO). 

This dynamic discussion covered design verification, control strategies, human factors, and post-approval changes. Drug Delivery Leader Chief Editor, Tom von Gunden, provided the overarching framework of the topic and guided audience responses during a concluding Q&A segment.